Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, +14

New England Journal of Medicine

Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study

Roos S. G. Sablerolles, Melvin Lafeber, Janneke A. L. van Kempen, +154

The Lancet Healthy Longevity

GeriatricsMedicineGlobal HealthHospital MortalityClinical Epidemiology +10

Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial

Melvin Lafeber, Diederick E. Grobbee, Ilse M. Schrover, +6

International Journal of Cardiology

HypertensionCardiovascular DiseaseCrossover TrialAntihypertensive TherapyMorning Polypill +5

The combined use of aspirin, a statin, and blood pressure–lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease

Melvin Lafeber, Wilko Spiering, Yolanda van der Graaf, +4

American Heart Journal

ThrombosisHypertensionBlood Pressure–lowering AgentsHealth PolicyCardiovascular Disease +9

Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline

Melvin Lafeber, Aline M.E. Stades, Gerlof D. Valk, +3

European Journal of Endocrinology

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

Ngoc H. Tan, Daryl Geers, Roos S. G. Sablerolles, +21

The Lancet Infectious Diseases

VaccinationVaccine SafetyDirect Boost GroupPreventive MedicineAllergy +7

Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

Michel Azizi, Andrew Sharp, Naomi D.L. Fisher, +609

Circulation

Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk

Melvin Lafeber, Wilko Spiering, Frank L.J. Visseren, +8

European Journal of Preventive Cardiology

HypertensionPotent StatinsCardiovascular PharmacologyPharmacotherapyFixed-dose Combination Pill +14

Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment

Arjen M. Punt, Nicolaas A. Stienstra, M.E.A. van Kleef, +5

Journal of Chromatography B

The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus

Melvin Lafeber, Diederick E. Grobbee, Wilko Spiering, +3

European Journal of Preventive Cardiology